These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1362 related articles for article (PubMed ID: 26487518)
1. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway. Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518 [TBL] [Abstract][Full Text] [Related]
2. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice. Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871 [TBL] [Abstract][Full Text] [Related]
3. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats. Lian R; Chen Y; Xu Z; Zhang X Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497 [TBL] [Abstract][Full Text] [Related]
4. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation. Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247 [TBL] [Abstract][Full Text] [Related]
5. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction. Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222 [TBL] [Abstract][Full Text] [Related]
6. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1. Ma J; Ma SY; Ding CH Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464 [TBL] [Abstract][Full Text] [Related]
7. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction. Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381 [TBL] [Abstract][Full Text] [Related]
8. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis. Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216 [TBL] [Abstract][Full Text] [Related]
9. microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling. Yang F; Li P; Li H; Shi Q; Li S; Zhao L J Cardiovasc Pharmacol; 2015 May; 65(5):456-64. PubMed ID: 25636075 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1. Liu X; Xu Y; Deng Y; Li H Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569 [TBL] [Abstract][Full Text] [Related]
11. Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7. Yuan J; Chen H; Ge D; Xu Y; Xu H; Yang Y; Gu M; Zhou Y; Zhu J; Ge T; Chen Q; Gao Y; Wang Y; Li X; Zhao Y Cell Physiol Biochem; 2017; 42(6):2207-2219. PubMed ID: 28817807 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway. Li B; Chen H; Yang X; Wang Y; Qin L; Chu Y Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):97-101. PubMed ID: 27453280 [TBL] [Abstract][Full Text] [Related]
13. A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis. Liang H; Zhang C; Ban T; Liu Y; Mei L; Piao X; Zhao D; Lu Y; Chu W; Yang B Int J Biochem Cell Biol; 2012 Dec; 44(12):2152-60. PubMed ID: 22960625 [TBL] [Abstract][Full Text] [Related]
15. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701 [TBL] [Abstract][Full Text] [Related]
16. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling. Sassoli C; Chellini F; Pini A; Tani A; Nistri S; Nosi D; Zecchi-Orlandini S; Bani D; Formigli L PLoS One; 2013; 8(5):e63896. PubMed ID: 23704950 [TBL] [Abstract][Full Text] [Related]
17. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor. Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055 [TBL] [Abstract][Full Text] [Related]
18. Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure. Zhang F; Dang Y; Li Y; Hao Q; Li R; Qi X Cell Physiol Biochem; 2016; 39(1):294-302. PubMed ID: 27344462 [TBL] [Abstract][Full Text] [Related]
19. Histone methyltransferase DOT1L mediates the TGF-β1/Smad3 signaling pathway through epigenetic modification of SYK in myocardial infarction. Li F; Li L; Zhang J; Yang X; Liu Y Hum Cell; 2022 Jan; 35(1):98-110. PubMed ID: 34635982 [TBL] [Abstract][Full Text] [Related]
20. Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts. Li T; Zhuang Y; Yang W; Xie Y; Shang W; Su S; Dong X; Wu J; Jiang W; Zhou Y; Li Y; Zhou X; Zhang M; Lu Y; Pan Z FASEB J; 2021 Feb; 35(2):e21162. PubMed ID: 33150686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]